Phlebotomists

31-9097.00
Median wage $45,230/yr143,540 employed (US)Rank #829 of 923 scored · top 90% by substitution

Draw blood for tests, transfusions, donations, or research. May explain the procedure to patients and assist in the recovery of patients with adverse reactions.

Sub-scores

0–100 · band = confidence interval from rater disagreement

Substitution14
Exposure12
Augmentation34

Substitution — the headline: capability discounted by cost, barriers and adoption.

Exposure — technical capability alone, regardless of whether anyone deploys it.

Augmentation — how much AI assists without replacing. High here + moderate substitution = a changing job, not a disappearing one.

Tasks on the substitution scale

23 rated tasks, binned by substitution score.

Position among all scored occupations

Distribution of 923 occupation scores; the marker is this occupation.

Tasks with substitution ≥ 70

0%

Run 1.0.0-draft.1 · computed 2026-08-05 · rater panel: claude-sonnet-5, claude-haiku-4-5-20251001 · intervals span rater disagreement.

Why this score

The five weighted dimensions of the composite, averaged across this occupation's tasks (importance-weighted, panel mean). Exact weights and formulas: /api/v1/methodology.

Task automatabilityw 35%11

panel mean rating 1.5/5 → substitution pressure 11/100

Technical feasibility todayw 20%14

panel mean rating 1.6/5 → substitution pressure 14/100

Cost vs. human wagew 15%14

panel mean rating 1.5/5 → substitution pressure 14/100

Adoption barriersw 20%inverted — strong barriers lower the score18

panel mean rating 4.3/5 (barrier strength) → substitution pressure 18/100

Sector adoption velocityw 10%12

panel mean rating 1.5/5 → substitution pressure 12/100

Task breakdown (23 tasks)

Substitution pressure per task, weighted by O*NET importance in the composite. Expand a task for the full rater audit trail — every rating, every model, every rationale.

Enter patient, specimen, insurance, or billing information into computer.

69

CI 62–75 · exposure 70 · augmentation 75 · importance 4.4/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510014/5Healthcare organizations, especially hospitals and large clinics, have been rapidly adopting EHR automation and AI-assisted data capture over the past 5–10 years. Adoption is measurable and widespread in digitized healthcare settings, though smaller facilities may lag.
Sector adoption velocityclaude-sonnet-53/5Healthcare has moderate digitization with EHR adoption widespread, but administrative automation lags due to regulatory complexity, legacy IT systems, and cautious rollout in clinical settings.
Augmentation potentialclaude-haiku-4-5-202510014/5AI significantly augments phlebotomists by auto-populating fields, catching obvious errors, and reducing manual keyboard entry time. This preserves the human judgment for complex cases while raising overall data-entry throughput and accuracy.
Augmentation potentialclaude-sonnet-54/5AI-assisted data entry tools (auto-fill, speech-to-text, barcode scanning) meaningfully speed up this task for phlebotomists while they remain responsible for verification and oversight.
Task automatabilityclaude-haiku-4-5-202510014/5Data entry from patient records, specimens, insurance, and billing information can be largely automated through optical character recognition (OCR), form parsing, and structured data extraction from electronic health records (EHRs). Current AI systems can achieve >50% time savings for this routine, rule-based task, though some verification may remain necessary.
Task automatabilityclaude-sonnet-54/5Data entry of structured patient, specimen, insurance, and billing information is a well-defined text/data task that current AI and automation (OCR, EHR integrations, voice-to-text) can largely handle, though clinical workflow integration limits full automation without setup.
Adoption barriersclaude-haiku-4-5-202510013/5Healthcare is regulated (HIPAA, state licensure) and many organizations require human verification or phlebotomist sign-off on specimen data for liability and audit trails. However, data entry itself is not legally reserved to licensed personnel, creating moderate—not hard—barriers to full automation.
Adoption barriersclaude-sonnet-52/5No licensure is required specifically for data entry, though HIPAA compliance and accuracy requirements create some oversight friction; the entry itself isn't inherently protected work.
Cost vs. human wageclaude-haiku-4-5-202510014/5The cost of AI-powered data entry (OCR, form processing, EHR integration) is substantially cheaper than the loaded hourly wage of a phlebotomist performing manual entry, particularly at scale. A single implementation serves many transactions with minimal marginal cost per entry.
Cost vs. human wageclaude-sonnet-54/5Automated data capture (barcode scanners, integrated EHR entry, OCR) is far cheaper per transaction than paying a phlebotomist's time for manual entry, though initial integration costs exist.
Technical feasibility todayclaude-haiku-4-5-202510014/5Deployed healthcare software and EHR systems with integrated AI-assisted data entry, auto-population from scanned documents, and intelligent form-filling are widely used in production across hospitals and clinics. These systems reliably perform most of this task, though they typically require human review for complex or ambiguous entries.
Technical feasibility todayclaude-sonnet-53/5EHR systems increasingly offer barcode scanning, voice dictation, and auto-population features in production, but many phlebotomy settings still rely on manual entry due to legacy systems and integration gaps.

Conduct standards tests, such as blood alcohol, blood culture, oral glucose tolerance, glucose screening, blood smears, or peak and trough drug levels tests.

45

CI 0–90 · exposure 50 · augmentation 50 · importance 4.7/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510015/5Hospital and commercial laboratory automation is mature and deeply embedded; large diagnostic networks (LabCorp, Quest) have systematically deployed automated analyzers for decades, with widespread production use across urban and well-resourced settings.
Sector adoption velocityclaude-sonnet-51/5Healthcare specimen collection is a highly physical, regulated task with minimal AI/robotic adoption in production settings.
Augmentation potentialclaude-haiku-4-5-202510014/5AI systems assist phlebotomists and technicians by flagging abnormal results, suggesting reflex testing, and reducing manual review burden; while the machine handles the analytical work, human expertise in result interpretation and clinical correlation remains valuable.
Augmentation potentialclaude-sonnet-52/5AI can assist with scheduling, documentation, or interpreting some lab results, but offers little direct support for the physical test administration itself.
Task automatabilityclaude-haiku-4-5-202510015/5Once blood samples are collected, the entire analytical workflow—standards testing, result interpretation, and report generation—can be performed end-to-end by automated laboratory analyzers and AI systems with documented time savings exceeding 50% and high consistency compared to manual analysis.
Task automatabilityclaude-sonnet-51/5This requires physical venipuncture, sample handling, and adherence to precise protocols on a live patient, which current AI systems cannot perform without robotic embodiment far beyond deployed capability.
Adoption barriersclaude-haiku-4-5-202510013/5While regulatory oversight (CLIA/CAP) requires documented procedures and competent operation, analyzers themselves are not legally restricted; however, supervisory oversight, quality assurance sign-off by licensed personnel, and organizational inertia in smaller labs create moderate friction to full displacement.
Adoption barriersclaude-sonnet-55/5Drawing blood and performing certain diagnostic tests requires licensed, trained personnel under clinical regulations, with legal and safety liability tied to human execution.
Cost vs. human wageclaude-haiku-4-5-202510015/5High-throughput automated analyzers process hundreds of samples per hour at per-test costs substantially below the loaded wage of a phlebotomist or lab technician performing manual analysis, achieving orders-of-magnitude savings at volume.
Cost vs. human wageclaude-sonnet-51/5There is no viable AI substitute for the physical act of blood draw and specimen handling, so any AI-based alternative would be more costly or simply nonfunctional relative to a phlebotomist's wage.
Technical feasibility todayclaude-haiku-4-5-202510015/5Large clinical and diagnostic laboratories deploy mature, FDA-cleared automated hematology, chemistry, and toxicology analyzers in production at scale; these systems reliably perform blood alcohol, glucose tolerance, drug level, and blood culture screening with established quality control.
Technical feasibility todayclaude-sonnet-51/5No deployed AI product performs blood draws or physical specimen collection and testing procedures; this remains a manual clinical task requiring human dexterity and judgment.

Document route of specimens from collection to laboratory analysis and diagnosis.

32

CI 28–37 · exposure 30 · augmentation 63 · importance 4.4/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510013/5Hospitals and larger laboratories have adopted LIS and barcode tracking systems at moderate rates, but smaller facilities lag significantly. Adoption focuses on assisting rather than replacing phlebotomist documentation responsibilities.
Sector adoption velocityclaude-sonnet-53/5Healthcare and clinical labs have moderate digitization with barcode/LIMS systems common in larger facilities, but adoption is uneven across smaller clinics and adoption of AI-driven documentation specifically is still nascent.
Augmentation potentialclaude-haiku-4-5-202510014/5AI-assisted barcode scanning, automated data capture, and real-time tracking dashboards substantially improve phlebotomists' efficiency in documenting specimen routes and reduce manual entry errors while maintaining human oversight of the process.
Augmentation potentialclaude-sonnet-53/5Digital tracking systems and voice-to-text or scanning tools assist phlebotomists in logging specimen routes faster and more accurately, though the core documentation task still requires human action at each handoff.
Task automatabilityclaude-haiku-4-5-202510012/5While AI can assist with data entry and tracking, the task requires real-time monitoring of specimen movement, chain-of-custody verification, and integration with multiple laboratory systems. Current systems can automate parts of documentation but cannot fully replace phlebotomists' responsibility for ensuring specimen integrity throughout the route.
Task automatabilityclaude-sonnet-52/5Documenting chain-of-custody for specimens requires physical tracking, barcode scanning, and integration with lab systems; some logging can be templated but the physical handling and verification steps resist full automation.
Adoption barriersclaude-haiku-4-5-202510014/5Strict regulatory requirements (CLIA, CAP) mandate documented chain-of-custody and require human accountability for specimen integrity. Liability for specimen loss or misidentification falls on the laboratory and authorized personnel, creating legal barriers to full automation without human sign-off.
Adoption barriersclaude-sonnet-53/5Chain-of-custody documentation for clinical specimens is subject to regulatory and accreditation requirements (e.g., CLIA), requiring accurate human-verified records, though not necessarily requiring a licensed sign-off for each log entry.
Cost vs. human wageclaude-haiku-4-5-202510012/5Implementing robust AI-driven tracking systems requires significant infrastructure investment, integration with legacy LIS, and ongoing oversight. The loaded cost per specimen tracked often exceeds the portion of phlebotomist labor devoted to documentation alone.
Cost vs. human wageclaude-sonnet-52/5Existing LIMS software reduces incremental documentation cost, but the phlebotomist must still perform physical scanning/logging alongside the draw, so net cost savings versus the human labor are modest.
Technical feasibility todayclaude-haiku-4-5-202510012/5Laboratory information systems (LIS) exist to track specimens, but they require manual input at multiple handoff points and rely on human oversight. No fully autonomous AI system currently performs end-to-end specimen tracking without human validation and intervention.
Technical feasibility todayclaude-sonnet-53/5LIMS and barcode-tracking software are widely deployed in labs and reliably log specimen chain-of-custody, though phlebotomists still manually initiate and verify each step.

Explain fluid or tissue collection procedures to patients.

28

CI 25–30 · exposure 25 · augmentation 50 · importance 4.1/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5Healthcare adoption of AI for patient-facing communication remains cautious and pilot-stage; institutions favor human phlebotomists for the trust-building and responsiveness this task demands. No evidence of meaningful displacement in production healthcare settings.
Sector adoption velocityclaude-sonnet-52/5Healthcare, especially routine clinical/phlebotomy settings, adopts AI slowly for patient-facing interpersonal tasks due to regulatory, trust, and workflow integration challenges.
Augmentation potentialclaude-haiku-4-5-202510013/5AI can assist by drafting procedure explanations, generating visual aids, or providing talking points for phlebotomists to deliver, thereby improving consistency and reducing prep time. However, the phlebotomist remains the primary communicator, making this a moderate productivity aid rather than transformative.
Augmentation potentialclaude-sonnet-53/5AI-generated multilingual materials, videos, or chatbot pre-briefings can supplement and standardize what patients are told, improving consistency and saving some verbal repetition time for phlebotomists.
Task automatabilityclaude-haiku-4-5-202510012/5While AI can generate explanations of procedures, delivering them requires real-time responsiveness to patient anxiety, comprehension checks, and cultural sensitivity. Current systems cannot reliably adapt explanations mid-conversation or detect non-verbal distress cues that phlebotomists routinely manage, so meaningful automation is limited.
Task automatabilityclaude-sonnet-52/5While AI can generate explanatory scripts or videos, the actual in-person, real-time explanation tailored to patient anxiety, comprehension, and physical presence during a live procedure requires human interaction that current AI cannot fully replace end-to-end.
Adoption barriersclaude-haiku-4-5-202510014/5Patient safety, informed consent, and liability create strong barriers: a human phlebotomist must directly inform the patient per regulatory and institutional policy. Patients expect and prefer human interaction during a medical procedure, and regulatory frameworks typically require direct practitioner-to-patient communication for consent.
Adoption barriersclaude-sonnet-53/5No strict licensing requirement mandates a human explain the procedure, but patient comfort, consent processes, and the need for immediate human presence during the physical procedure create practical friction.
Cost vs. human wageclaude-haiku-4-5-202510012/5AI-generated explanations (text or video templates) have low marginal cost, but integration into a clinical workflow and oversight to ensure accuracy and adequacy requires human involvement. The savings over a phlebotomist's brief verbal explanation are modest when factoring in setup and validation.
Cost vs. human wageclaude-sonnet-52/5Producing static educational content is cheap, but real-time in-person explanation still requires a human present for the procedure itself, so AI doesn't meaningfully reduce the labor cost of this specific moment.
Technical feasibility todayclaude-haiku-4-5-202510012/5Chatbots can explain procedures in text or scripted video, but no deployed product reliably replaces a phlebotomist's live explanation—which involves observing patient reactions, answering unexpected questions, and building trust. This remains largely a training/template aid, not a functional substitute.
Technical feasibility todayclaude-sonnet-52/5Patient education chatbots and pre-visit informational videos exist, but no deployed product reliably replaces the live, adaptive verbal explanation phlebotomists give immediately before a blood draw.

Match laboratory requisition forms to specimen tubes.

24

CI 23–25 · exposure 25 · augmentation 50 · importance 4.8/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Phlebotomy remains a largely manual, decentralized function across thousands of small and mid-size clinical labs with limited AI investment. Adoption of specimen-matching automation is minimal in production, constrained by regulatory caution and the low digitization of legacy lab workflows.
Sector adoption velocityclaude-sonnet-52/5Healthcare specimen collection is a physical, highly regulated environment with historically slow AI/automation adoption compared to information-sector tasks.
Augmentation potentialclaude-haiku-4-5-202510013/5AI-assisted barcode scanning and flagging of potential tube–requisition mismatches could provide moderate productivity gains by reducing manual visual checking, though the phlebotomist must retain final verification authority. This assistive role is achievable and could reduce error rates.
Augmentation potentialclaude-sonnet-53/5Barcode scanners and LIS alerts already assist phlebotomists in verifying matches and flagging discrepancies, improving accuracy and speed while the human remains responsible for final verification.
Task automatabilityclaude-haiku-4-5-202510012/5While AI could identify labels and text on requisition forms and tubes via OCR/vision, the physical matching task—ensuring correct specimen tubes are paired with corresponding requisitions—requires human-level spatial reasoning and error tolerance that current systems struggle with at scale. Partial automation (flagging potential mismatches) is feasible, but end-to-end matching with ≥50% time savings at equal quality is not yet demonstrated.
Task automatabilityclaude-sonnet-52/5This requires physical handling and verification of tubes against paperwork/labels, tied to physical specimen collection; current AI can assist with barcode/label verification but cannot end-to-end replace the physical matching and error-checking process.
Adoption barriersclaude-haiku-4-5-202510014/5Healthcare settings operate under strict regulatory oversight (CLIA, CAP) with legal liability for specimen misidentification, which carries severe clinical and financial consequences. Any automation would require validation, regulatory approval, and institutional liability review, creating substantial friction against substitution.
Adoption barriersclaude-sonnet-54/5Patient safety regulations and lab accreditation standards (e.g., CLIA) require verified chain-of-custody and often mandate human verification steps, creating strong liability and regulatory barriers to full automation.
Cost vs. human wageclaude-haiku-4-5-202510012/5Implementing vision systems, barcode readers, and integration infrastructure for matching would require significant capital and ongoing infrastructure costs, likely exceeding the relatively low labor cost of phlebotomists performing this task. Cost parity or AI advantage is not yet evident in practice.
Cost vs. human wageclaude-sonnet-52/5Automated barcode/label matching systems exist but require hardware integration, LIS interfacing, and human oversight, so all-in costs are not dramatically cheaper than a phlebotomist performing this quick manual check.
Technical feasibility todayclaude-haiku-4-5-202510012/5Some computer vision systems can read barcodes and text on tubes and forms, but no production system reliably solves the full matching problem across diverse clinical environments with the accuracy (near-zero error rate) required in healthcare. Prototype and research demonstrations exist but not mature field deployment.
Technical feasibility todayclaude-sonnet-52/5Barcode scanning and lab information systems provide some automated verification, but full autonomous matching without human oversight is not deployed at scale in clinical settings due to patient safety requirements.

Provide sample analysis results to physicians to assist diagnosis.

23

CI 16–29 · exposure 17 · augmentation 50 · importance 4.5/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5Healthcare lab automation is advancing, but it focuses on instrumentation and workflow optimization rather than replacing the phlebotomist's role in diagnostic communication; adoption of AI for autonomous result interpretation and physician communication remains in pilot/research phases, not production displacement.
Sector adoption velocityclaude-sonnet-52/5Healthcare, especially lab/clinical support roles, has historically been slower to adopt AI-driven automation due to regulatory and safety concerns, despite EHR digitization.
Augmentation potentialclaude-haiku-4-5-202510013/5AI tools can assist phlebotomists by flagging critical values, suggesting differential diagnoses, and auto-formatting reports, meaningfully improving their efficiency and accuracy in presenting findings to physicians, though the human remains the decision-maker.
Augmentation potentialclaude-sonnet-53/5AI can help flag abnormal results, prioritize urgent cases, or draft summary notes for physicians, providing moderate assistance while humans remain responsible for reporting and communication.
Task automatabilityclaude-haiku-4-5-202510011/5Providing sample analysis results to physicians requires interpreting clinical lab data, contextualizing results within patient history, and communicating diagnostic assistance—functions that demand medical judgment and accountability that current AI cannot reliably perform end-to-end without human phlebotomist or pathologist oversight.
Task automatabilityclaude-sonnet-52/5The physical drawing and handling of blood samples cannot be automated, but the reporting/transmission of results to physicians is largely already handled by lab information systems rather than AI reasoning, limiting AI's incremental automation potential here.
Adoption barriersclaude-haiku-4-5-202510014/5Clinical lab results and diagnostic communication to physicians are heavily regulated by CLIA, CAP, and state licensing; phlebotomists and clinical pathologists have legal and liability responsibility for accuracy, and many jurisdictions require a licensed professional to sign off on results provided to physicians.
Adoption barriersclaude-sonnet-54/5Clinical result reporting is subject to healthcare regulations (HIPAA, CLIA) and typically requires certified personnel or validated systems, creating meaningful compliance and liability barriers.
Cost vs. human wageclaude-haiku-4-5-202510012/5AI systems for lab data processing exist but require significant human oversight, validation, and integration costs; the all-in cost per task remains comparable to or higher than a phlebotomist's time because human verification is still mandatory.
Cost vs. human wageclaude-sonnet-53/5Automated data transmission is cheap, but this task as performed by phlebotomists is a small communication step already low-cost; AI doesn't dramatically undercut existing lab IT costs.
Technical feasibility todayclaude-haiku-4-5-202510012/5While AI can extract and format lab values from data systems and suggest reference ranges, no deployed product reliably interprets complex sample results and communicates diagnostic implications to physicians without human review; this remains largely a manual process requiring trained personnel.
Technical feasibility todayclaude-sonnet-52/5Lab information systems already route results automatically, but AI systems that analyze and contextualize results for physicians in a clinically validated way are still narrow and not standard practice at scale for phlebotomists' role in this task.

Determine donor suitability, according to interview results, vital signs, and medical history.

23

CI 23–23 · exposure 25 · augmentation 50 · importance 4.2/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Blood banks and donation centers operate in a highly regulated, compliance-driven sector with strong cultural preference for licensed personnel making safety-critical decisions; automation adoption in this context remains minimal and cautious despite digital integration elsewhere.
Sector adoption velocityclaude-sonnet-51/5Blood donation and phlebotomy services are a low-digitization, physical, highly regulated healthcare niche with minimal reported AI agent deployment for donor screening decisions.
Augmentation potentialclaude-haiku-4-5-202510013/5AI could usefully assist phlebotomists by auto-populating historical records, flagging known contraindications, or summarizing vital signs trends, reducing manual lookup time while the human retains final judgment on donor suitability.
Augmentation potentialclaude-sonnet-53/5AI-based decision support (e.g., checklists, risk-flagging from history/vitals) can help phlebotomists more efficiently review medical history and flag inconsistencies, aiding but not replacing their judgment.
Task automatabilityclaude-haiku-4-5-202510012/5While AI could assist in reviewing medical history and vital signs against eligibility criteria, phlebotomists must make real-time clinical judgment calls that integrate subtle human observations, patient interview nuance, and contextual knowledge that current AI systems struggle to replicate reliably. The task requires handling exceptions, edge cases, and deferral decisions that fall short of the 50% time-saving threshold at equal safety quality.
Task automatabilityclaude-sonnet-52/5This task combines interview judgment, physical vital sign assessment, and medical history synthesis into a suitability decision; current AI can support parts (data aggregation, flagging risks) but cannot end-to-end perform the interview and physical assessment steps reliably today.
Adoption barriersclaude-haiku-4-5-202510014/5Regulatory frameworks (FDA, blood banking standards, transfusion medicine protocols) typically require a qualified human healthcare worker to make eligibility determinations, and donor safety liability creates strong organizational and legal incentives to retain human sign-off. This is a human-contact task with material error-cost asymmetry.
Adoption barriersclaude-sonnet-54/5Blood donation suitability determinations are governed by regulatory (e.g., FDA) requirements and typically require a qualified/trained healthcare worker to make the eligibility call, creating a strong barrier to full automation.
Cost vs. human wageclaude-haiku-4-5-202510012/5Implementation would require oversight, integration with donor management systems, and continued human verification for edge cases, making the all-in cost comparable to or exceeding the loaded wage of a phlebotomist performing the task.
Cost vs. human wageclaude-sonnet-52/5Given the need for human vital sign measurement and interview interaction plus liability oversight, AI assistance layered on top of a human phlebotomist does not yet produce large all-in cost savings.
Technical feasibility todayclaude-haiku-4-5-202510012/5No deployed product reliably performs independent donor suitability assessment; existing screening tools are rule-based and narrow in scope. AI systems can flag obvious disqualifiers but lack the contextual reasoning and liability acceptance to replace phlebotomist judgment in a production setting.
Technical feasibility todayclaude-sonnet-52/5There are clinical decision-support tools that flag donor eligibility issues from structured data, but no deployed product autonomously conducts the donor interview and makes the final suitability determination in production blood donation settings.

Train other medical personnel in phlebotomy or laboratory techniques.

21

CI 16–25 · exposure 17 · augmentation 63 · importance 4.1/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5Healthcare sectors adopt AI selectively and conservatively, especially for training; while some organizations use supplementary digital content, live phlebotomy training remains predominantly human-delivered due to safety and credentialing norms, resulting in slow adoption of automation in this domain.
Sector adoption velocityclaude-sonnet-52/5Healthcare training programs are adopting AI slowly for supplementary content (quizzes, videos) but practical skills labs remain human-led, reflecting healthcare's generally slower AI adoption for hands-on tasks.
Augmentation potentialclaude-haiku-4-5-202510013/5AI can assist instructors by generating practice scenarios, video modules, quizzes, and interactive simulations that trainees review before or between live sessions, moderately enhancing the instructor's productivity without removing them from the critical feedback and certification loop.
Augmentation potentialclaude-sonnet-54/5AI can meaningfully augment training via personalized quizzes, video demonstrations, simulation feedback, and knowledge assessment, improving efficiency while humans still supervise physical skill practice.
Task automatabilityclaude-haiku-4-5-202510011/5Training requires adaptive instruction, assessment of learner comprehension, hands-on demonstration correction, and interpersonal responsiveness—capabilities far beyond current AI automation. No end-to-end system can replace the human instructor's ability to observe skill execution, adjust teaching in real-time, and provide mentoring.
Task automatabilityclaude-sonnet-52/5Training involves hands-on demonstration, physical technique correction, and live supervision of needle insertion skills that current AI cannot perform; AI can supplement written/video content but not replace the physical instruction core.rica
Adoption barriersclaude-haiku-4-5-202510014/5Training in phlebotomy and laboratory techniques touches patient safety and procedural certification; most healthcare organizations have regulatory and accreditation requirements that qualified human instructors must conduct or validate hands-on training, creating legal and institutional barriers to full automation.
Adoption barriersclaude-sonnet-54/5Clinical competency certification typically requires supervised practice and sign-off by a qualified professional, creating a strong regulatory/liability barrier to full automation of hands-on training.
Cost vs. human wageclaude-haiku-4-5-202510012/5Current AI tools (video generation, content authoring) reduce preparation time modestly, but the core training task still requires a human instructor, making total cost savings marginal and often offset by integration overhead for medical compliance.
Cost vs. human wageclaude-sonnet-52/5AI-assisted training materials are cheap to produce, but the human trainer still must supervise practical skill-building, so overall cost savings versus a qualified human trainer are limited.
Technical feasibility todayclaude-haiku-4-5-202510012/5While AI can generate training materials or video content, no deployed system reliably conducts live, interactive training with skill verification and personalized feedback at the quality expected in medical settings. Products exist for content generation but not for end-to-end training delivery.
Technical feasibility todayclaude-sonnet-52/5AI-based e-learning modules and video tutorials exist for medical training generally, but no deployed product independently trains hands-on phlebotomy technique to competency without human instructors.

Conduct hemoglobin tests to ensure donor iron levels are normal.

15

CI 5–25 · exposure 13 · augmentation 50 · importance 4.3/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5Blood donation facilities are moderately digitized but remain conservative in adopting automated screening. Adoption of hemoglobin analyzers is widespread, but as tools that augment human phlebotomists rather than replacing the core task; displacement of phlebotomists themselves is minimal.
Sector adoption velocityclaude-sonnet-51/5Phlebotomy and blood donation testing remain highly manual, physically-mediated healthcare tasks with minimal AI adoption in the actual test administration.
Augmentation potentialclaude-haiku-4-5-202510014/5Hemoglobin analyzers substantially assist phlebotomists by providing instant, objective results that inform eligibility decisions and reduce manual calculation burden. This raises productivity and safety while keeping the human in the loop for final eligibility determination and donor communication.
Augmentation potentialclaude-sonnet-52/5AI could assist with recordkeeping, flagging abnormal results, or scheduling, but offers little augmentation to the physical act of testing itself.
Task automatabilityclaude-haiku-4-5-202510012/5While hemoglobin testing devices can automate the measurement step, the task involves physical blood sample collection and interpretation in context of donor eligibility, which currently requires human judgment and direct patient interaction. No end-to-end system achieves 50% time savings at equal quality today.
Task automatabilityclaude-sonnet-51/5This requires physical execution of a finger-stick blood draw and reading a point-of-care device, which is a manual clinical procedure that current AI cannot perform end-to-end without robotics not yet deployed in this setting.
Adoption barriersclaude-haiku-4-5-202510014/5Strong regulatory and safety barriers exist: phlebotomy requires licensure/certification in most jurisdictions, blood contact poses infection risk, and donor screening decisions carry legal liability. Blood product safety is heavily regulated (FDA, AABB standards), creating hard barriers to full automation.
Adoption barriersclaude-sonnet-54/5Blood collection and point-of-care testing typically require certified/licensed personnel under clinical safety regulations, creating strong barriers to non-human performance of this task.
Cost vs. human wageclaude-haiku-4-5-202510012/5Hemoglobin testing devices are relatively inexpensive (~$500–$2,000 capital), but labor savings are minimal since phlebotomists must still perform venipuncture, patient assessment, and clinical judgment. The per-test cost advantage is modest and does not approach an order of magnitude savings.
Cost vs. human wageclaude-sonnet-51/5There is no AI substitute performing this physical task, so AI cost is not comparable to human cost; a human phlebotomist remains necessary for the procedure.
Technical feasibility todayclaude-haiku-4-5-202510012/5Automated hemoglobin analyzers exist in production (e.g., portable hemoglobin meters), but they perform only the measurement component. The full task—screening, sample collection, result interpretation, and donor eligibility decision—remains dependent on human phlebotomists; no integrated system reliably handles the complete task autonomously.
Technical feasibility todayclaude-sonnet-51/5No deployed AI product performs the physical hemoglobin testing procedure; existing devices are simple hardware analyzers operated by trained humans, not AI-driven automation of the task.

Transport specimens or fluid samples from collection sites to laboratories.

11

CI 5–16 · exposure 5 · augmentation 38 · importance 4.3/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5Adoption is limited and slow. Most healthcare facilities still rely on human couriers or low-tech pneumatic systems rather than autonomous AI-driven transport. Digital health integration is advancing, but physical specimen logistics remains labor-intensive with high resistance to change due to safety and liability concerns.
Sector adoption velocityclaude-sonnet-51/5Healthcare specimen logistics remains a low-digitization, physically-mediated process with minimal AI/robotic adoption in production settings.
Augmentation potentialclaude-haiku-4-5-202510013/5AI can assist with route optimization, specimen tracking, temperature monitoring alerts, and documentation management, improving efficiency and reducing delays. However, the core physical transport and handling still require human judgment and accountability, so assistance is meaningful but not transformative.
Augmentation potentialclaude-sonnet-52/5AI can assist with route optimization, tracking, and scheduling of specimen transport, but does not materially change the physical task itself.
Task automatabilityclaude-haiku-4-5-202510011/5Transporting physical specimens requires navigating physical environments, handling fragile samples, and managing chain-of-custody documentation in ways that current robotics and AI cannot reliably do at scale in hospital/clinic settings. This task is fundamentally dependent on embodied logistics without viable full-end-to-end automation today.
Task automatabilityclaude-sonnet-51/5This is a physical transport task requiring movement of biological samples between locations; no off-the-shelf AI system can perform this end-to-end without robotics/logistics infrastructure.'
Adoption barriersclaude-haiku-4-5-202510014/5Specimen transport falls under clinical chain-of-custody and regulatory requirements (CLIA, CAP) that mandate documented handling and verification. Many facilities require documented human accountability for specimen integrity, and liability concerns make full autonomous transport risky without human oversight and legal backup.
Adoption barriersclaude-sonnet-54/5Chain-of-custody, biohazard handling regulations, and liability for sample integrity create strong regulatory and safety barriers to non-human transport methods.
Cost vs. human wageclaude-haiku-4-5-202510012/5Automated logistics systems (pneumatic tubes, transport robots) have high upfront capital costs and maintenance requirements that often exceed the wage cost of a phlebotomist or dedicated courier, particularly in smaller or mid-sized facilities. Operational integration costs are substantial.
Cost vs. human wageclaude-sonnet-51/5Without an automated physical delivery system, AI has no direct cost advantage; any automation would require capital-intensive robotics/drones that are not commonly deployed at scale for this purpose.
Technical feasibility todayclaude-haiku-4-5-202510012/5While some hospitals deploy pneumatic tube systems or simple logistics robots for specimen transport, these operate on fixed routes and require substantial infrastructure investment. Current AI-based solutions cannot independently navigate unpredictable healthcare environments or handle exceptions (delays, misrouted samples, damage assessment) reliably enough to meet clinical standards.
Technical feasibility todayclaude-sonnet-51/5No deployed AI product autonomously transports clinical specimens today; this remains a manual or human-driven courier/logistics function.

Serve refreshments to donors to ensure absorption of sugar into their systems.

7

CI 5–10 · exposure 0 · augmentation 13 · importance 3.7/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Healthcare and blood donation centers remain low-digitization sectors for this specific task; adoption of physical automation in donor-facing roles is minimal and moving slowly.
Sector adoption velocityclaude-sonnet-51/5Blood donation centers are low-digitization, physical-service environments with minimal AI/robotics adoption for hands-on donor care tasks.
Augmentation potentialclaude-haiku-4-5-202510012/5AI could potentially provide reminders or guidance to phlebotomists about serving refreshments based on donor history or intake data, but this is narrow assistance that does not substantially transform their productivity.
Augmentation potentialclaude-sonnet-51/5AI offers no meaningful assistance for the physical act of serving refreshments and watching for donor reactions on-site.
Task automatabilityclaude-haiku-4-5-202510011/5This task requires physical interaction with donors (serving refreshments) and real-time assessment of individual health conditions. Current AI systems cannot physically manipulate or hand objects to people, and the medical judgment about what and when to serve requires human presence and responsiveness.
Task automatabilityclaude-sonnet-51/5This is a physical task requiring a person to hand out food/drink and monitor donor wellbeing in person; no AI system can perform this physical action.itude
Adoption barriersclaude-haiku-4-5-202510014/5High barriers exist due to direct human-contact requirement, medical supervision expectations, and implicit liability if automated systems miscalibrate or fail to serve donors appropriately after blood donation.
Adoption barriersclaude-sonnet-53/5No licensing requirement specifically for serving refreshments, but donor safety monitoring during recovery creates some liability/health-context friction requiring human presence.
Cost vs. human wageclaude-haiku-4-5-202510011/5Automation would require physical robots or remote systems to serve refreshments, which would be vastly more expensive than a phlebotomist performing this task as part of their routine donor care.
Cost vs. human wageclaude-sonnet-51/5AI has no mechanism to perform this physical service, so cost comparison favors the human worker entirely; robotics for this niche task would be far costlier than a low-wage staff member.
Technical feasibility todayclaude-haiku-4-5-202510011/5No deployed AI product performs this task end-to-end in production; it inherently requires human-agent interaction for physical service delivery and individualized health assessment at blood donation facilities.
Technical feasibility todayclaude-sonnet-51/5No deployed AI product serves physical refreshments or monitors post-donation recovery in person; this is purely a human physical-service task.

Organize or clean blood-drawing trays, ensuring that all instruments are sterile and all needles, syringes, or related items are of first-time use.

3

CI 0–5 · exposure 0 · augmentation 25 · importance 4.9/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Healthcare organizations, especially in phlebotomy, have adopted AI slowly in procedural areas due to regulatory constraints, liability concerns, and the existing efficiency of manual tray preparation. This task remains almost entirely manual in clinical practice.
Sector adoption velocityclaude-sonnet-51/5Healthcare physical task environments, especially direct patient-care supply handling, show minimal AI/robotic adoption due to physical dexterity and safety requirements.
Augmentation potentialclaude-haiku-4-5-202510012/5Current AI offers minimal assistance; computer vision could theoretically help flag missing items or document tray contents, but verification of sterility and safety compliance still requires full human judgment and accountability, limiting the augmentative value.
Augmentation potentialclaude-sonnet-52/5AI could support inventory tracking or expiration alerts for supplies, but it offers little direct assistance to the physical act of organizing and verifying sterile trays.
Task automatabilityclaude-haiku-4-5-202510011/5This task requires physical manipulation of instruments, verification of sterility (often through visual inspection and documentation checks), and handling of biohazardous materials in real-world clinical settings. Current AI systems cannot physically organize trays, verify sterile packaging integrity, or perform the tactile and sensory checks needed to ensure compliance with infection control standards.
Task automatabilityclaude-sonnet-51/5This requires physical manipulation of sterile equipment, verification of packaging, and hands-on tray organization—no current AI system can perform physical sterilization or handle medical instruments.
Adoption barriersclaude-haiku-4-5-202510015/5Strong regulatory and safety barriers exist: OSHA bloodborne pathogen standards, Clinical Laboratory Improvement Amendments (CLIA), and state regulations mandate that sterile procedures and instrument preparation meet specific compliance requirements. Healthcare organizations typically require documented human accountability for instrument sterility, and liability exposure for automated errors in this context is very high.
Adoption barriersclaude-sonnet-54/5Clinical safety, sterility, and infection-control regulations require trained personnel to handle and verify sterile medical instruments, creating strong practical and regulatory barriers to non-human execution.
Cost vs. human wageclaude-haiku-4-5-202510011/5The specialized robotics or vision systems required to handle sterile instruments and verify compliance would be substantially more expensive than the relatively quick manual work performed by a phlebotomist, especially when considering the liability and oversight costs of automation in a biohazard context.
Cost vs. human wageclaude-sonnet-51/5There is no viable AI substitute for physical sterile equipment handling, so the human cost is the only real option, making AI comparison moot or infeasible at any price.
Technical feasibility todayclaude-haiku-4-5-202510011/5No deployed AI system can perform this task end-to-end. While computer vision might theoretically identify instrument types, actual sterility verification, tray organization, and the handling of sharps require human oversight and physical capability that current robotics in phlebotomy settings do not reliably provide.
Technical feasibility todayclaude-sonnet-51/5No deployed AI product manages physical sterile supply organization or instrument handling in clinical settings; this remains entirely a manual, physical task.

Draw blood from veins by vacuum tube, syringe, or butterfly venipuncture methods.

3

CI 0–5 · exposure 0 · augmentation 25 · importance 4.8/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Phlebotomy occurs in healthcare settings—hospitals, clinics, labs—which are highly regulated, conservative, and dependent on human expertise. Current adoption of automation in phlebotomy is minimal; staffing shortages are addressed through hiring and scheduling, not robotics.
Sector adoption velocityclaude-sonnet-51/5Healthcare phlebotomy is a highly manual, in-person clinical task with minimal automation adoption; robotic venipuncture remains in early pilot/research stages, not deployed broadly.
Augmentation potentialclaude-haiku-4-5-202510012/5AI could assist with patient data lookup or vein mapping visualization (thermal imaging), but the core manual task of insertion and blood draw offers limited room for augmentation while a human phlebotomist performs it; the human remains the essential agent.
Augmentation potentialclaude-sonnet-52/5Vein-visualization imaging tools and ultrasound guidance devices assist phlebotomists in locating veins, but overall AI augmentation of the physical draw process is limited.
Task automatabilityclaude-haiku-4-5-202510011/5Phlebotomy requires precise physical manipulation in a sterile environment, locating veins through palpation and sight, and managing patient comfort and safety—capabilities far beyond current robotic or AI systems. No current automation can reliably perform end-to-end venipuncture on diverse patient populations.
Task automatabilityclaude-sonnet-51/5Venipuncture requires fine motor skill, tactile feedback, and physical dexterity to locate veins and insert needles into diverse human anatomy; no off-the-shelf AI system performs this physical task today.
Adoption barriersclaude-haiku-4-5-202510015/5Venipuncture is a controlled medical procedure; in most jurisdictions only licensed phlebotomists, nurses, or physicians may legally draw blood. Patient consent, liability for bruising or nerve injury, and clinical protocol requirements create hard regulatory and legal barriers to automation.
Adoption barriersclaude-sonnet-54/5Clinical blood draws involve direct patient contact, safety risk, and typically require certified personnel, creating strong regulatory and liability barriers to substitution.
Cost vs. human wageclaude-haiku-4-5-202510011/5The hardware, maintenance, and per-draw integration costs of any autonomous venipuncture system would far exceed the loaded wage of a phlebotomist (typically $15–25/hour all-in), especially accounting for the overhead of specialized equipment and sterilization.
Cost vs. human wageclaude-sonnet-51/5Any experimental automated blood-draw device would require expensive specialized hardware, calibration, and human oversight, making it costlier than a trained phlebotomist today.
Technical feasibility todayclaude-haiku-4-5-202510011/5No deployed commercial product performs venipuncture autonomously or reliably today. While robotic arm research exists in labs, no production system in hospitals or clinics performs this task without human phlebotomists, and regulatory barriers (FDA, clinical standards) remain substantial.
Technical feasibility todayclaude-sonnet-51/5Robotic venipuncture devices exist only as research prototypes (e.g., vein-finding robots in trials) and are not deployed in production clinical settings at scale.

Collect specimens at specific time intervals for tests, such as those assessing therapeutic drug levels.

3

CI 0–5 · exposure 0 · augmentation 25 · importance 4.7/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Healthcare adoption of AI in clinical procedures remains limited and cautious. Phlebotomy in particular is a bedside procedure with high patient contact, regulatory scrutiny, and organizational preference for human operators; adoption of automation here is minimal.
Sector adoption velocityclaude-sonnet-51/5Healthcare specimen collection is a physical, hands-on task in a sector with slow automation adoption for direct patient-contact procedures.
Augmentation potentialclaude-haiku-4-5-202510012/5AI could assist marginally with scheduling collection times or flagging critical results post-collection, but offers little productivity gain during the actual specimen-collection act itself, which remains human-dependent.
Augmentation potentialclaude-sonnet-52/5AI can help schedule collection times, flag therapeutic drug monitoring windows, or manage lab data, but offers little assistance to the physical draw itself.
Task automatabilityclaude-haiku-4-5-202510011/5Collecting blood specimens at specific intervals requires direct physical interaction with a patient's body (venipuncture), which current AI systems cannot perform. The task demands real-time clinical judgment, patient safety protocols, and physical manipulation—none of which are amenable to automation by deployed technology today.
Task automatabilityclaude-sonnet-51/5Requires physical venipuncture on a patient at precise timing, a manual dexterity and physical-presence task that current AI systems cannot perform end-to-end.
Adoption barriersclaude-haiku-4-5-202510015/5Phlebotomy is a licensed/regulated clinical procedure in most jurisdictions; a trained, licensed phlebotomist or nurse must perform or directly supervise specimen collection. Legal and liability barriers are substantial and prevent substitution regardless of technical capability.
Adoption barriersclaude-sonnet-54/5Blood draws typically require certified/licensed personnel following strict clinical protocols and timing requirements tied to patient safety and lab accuracy, creating strong regulatory and liability barriers.
Cost vs. human wageclaude-haiku-4-5-202510011/5The capital cost of a phlebotomy-capable robot, integration, maintenance, and per-draw inference would far exceed the loaded wage of a phlebotomist ($40–60K annually). Current technology makes automation economically unfeasible.
Cost vs. human wageclaude-sonnet-51/5There is no viable AI substitute for the physical collection act, so AI cost comparison is not applicable/AI is not cheaper since it cannot perform the task.
Technical feasibility todayclaude-haiku-4-5-202510011/5No deployed product performs phlebotomy end-to-end. While robotics research exists in laboratory settings, no production system reliably performs venipuncture or specimen collection on diverse patient populations in clinical environments.
Technical feasibility todayclaude-sonnet-51/5No deployed AI/robotic product reliably performs blood draws in production clinical settings; this remains a human manual skill.

Draw blood from capillaries by dermal puncture, such as heel or finger stick methods.

3

CI 0–5 · exposure 0 · augmentation 13 · importance 4.4/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Despite decades of research interest, phlebotomy remains almost entirely manual; adoption of robotic systems is negligible in real clinical practice, reflecting both technical immaturity and regulatory/liability constraints.
Sector adoption velocityclaude-sonnet-51/5Healthcare phlebotomy is a physical, hands-on task in a sector with low automation penetration for direct patient contact procedures.
Augmentation potentialclaude-haiku-4-5-202510011/5AI offers minimal assistance to phlebotomists during the actual draw itself; while documentation and scheduling systems exist, they do not meaningfully augment the core skill of accurate, safe capillary puncture.
Augmentation potentialclaude-sonnet-52/5AI offers minimal direct assistance to the physical act of puncture, though it may help with peripheral tasks like labeling, scheduling, or documentation.
Task automatabilityclaude-haiku-4-5-202510011/5Dermal blood draws require precise physical manipulation of needles and lancets on living patients, immediate adaptation to individual anatomy, and real-time judgment about blood flow—capabilities entirely beyond current robotic systems in clinical settings. No AI or deployed automation can reliably perform this invasive procedure without human execution.
Task automatabilityclaude-sonnet-51/5This is a precise physical manipulation task requiring fine motor skill, tactile feedback, and adaptation to patient anatomy that current AI systems (software or robotics) cannot perform end-to-end.
Adoption barriersclaude-haiku-4-5-202510015/5Clinical blood draws are strictly regulated by medical licensing boards, CLIA regulations, and facility credentialing requirements; only trained and certified humans are legally authorized to perform venipuncture and capillary puncture. Liability, patient safety, and regulatory compliance create hard barriers to substitution.
Adoption barriersclaude-sonnet-54/5Drawing blood is an invasive procedure typically requiring trained/certified personnel, with real liability and infection-control concerns, though not always a licensed-only act depending on jurisdiction.
Cost vs. human wageclaude-haiku-4-5-202510011/5The capital and software costs of a robotic phlebotomy system, combined with integration, validation, and error-handling infrastructure, far exceed the hourly labor cost of a phlebotomist; the economics are strongly unfavorable for automation.
Cost vs. human wageclaude-sonnet-51/5There is no viable AI/robotic substitute in production, so any hypothetical automation would require expensive specialized hardware far exceeding the low cost of a trained phlebotomist.
Technical feasibility todayclaude-haiku-4-5-202510011/5No commercial product performs capillary blood draws autonomously today; this remains a manual clinical skill requiring licensed or certified personnel in every deployed healthcare setting. Robotic phlebotomy systems exist only in research and remain unreliable for routine clinical use.
Technical feasibility todayclaude-sonnet-51/5No deployed product performs autonomous dermal puncture blood draws in clinical practice; robotic venipuncture devices remain experimental and don't address capillary sticks specifically.

Monitor blood or plasma donors during and after procedures to ensure health, safety, and comfort.

3

CI 0–5 · exposure 5 · augmentation 38 · importance 4.4/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Phlebotomy remains a low-digitization, human-contact-mandatory field; blood banks and donation centers show minimal AI adoption beyond basic administrative tasks, constrained by clinical requirements and small-firm operations.
Sector adoption velocityclaude-sonnet-51/5Healthcare and blood collection settings are low-digitization, physically-mediated environments with minimal AI adoption for direct patient monitoring during procedures.
Augmentation potentialclaude-haiku-4-5-202510013/5AI-assisted vital-sign dashboards or alert systems could help phlebotomists track multiple donors or flag concerning trends, but the phlebotomist remains essential for judgment, reassurance, and intervention.
Augmentation potentialclaude-sonnet-52/5Wearable sensors or basic vital-sign monitors can feed data to alert staff, offering modest assistance, but the core observation and response remain human-driven.
Task automatabilityclaude-haiku-4-5-202510011/5Monitoring donor health, safety, and comfort requires real-time physiological assessment, immediate interventions for adverse reactions, and empathetic human presence—tasks that current AI cannot perform end-to-end or meaningfully automate without a phlebotomist present.
Task automatabilityclaude-sonnet-51/5This task requires physical presence, hands-on observation of a person's vital signs, skin color, consciousness, and immediate physical response to adverse reactions like fainting or bleeding—none of which current AI can perform end-to-end.
Adoption barriersclaude-haiku-4-5-202510015/5Healthcare regulations, liability law, and medical practice standards legally require a licensed/trained human to directly monitor donors during phlebotomy; automation is prohibited by scope-of-practice and duty-of-care requirements.
Adoption barriersclaude-sonnet-55/5Donor safety monitoring during invasive procedures is subject to strict health and safety regulations requiring trained personnel physically present to respond to medical emergencies.
Cost vs. human wageclaude-haiku-4-5-202510011/5Sensor systems and monitoring infrastructure would add cost rather than reduce it; the human phlebotomist is the least expensive reliable monitor for donor safety during procedures.
Cost vs. human wageclaude-sonnet-51/5There is no viable AI substitute performing this physical monitoring task, so cost comparison favors the human by default; any sensor-based monitoring still requires human response capability nearby.
Technical feasibility todayclaude-haiku-4-5-202510012/5While AI could support vital-sign monitoring via sensors or alert systems, no deployed product reliably substitutes for live phlebotomist oversight; clinical judgment and rapid intervention in adverse events (vasovagal syncope, nerve damage) remain human-dependent.
Technical feasibility todayclaude-sonnet-51/5No deployed AI product monitors donors physically during blood draws; this remains an in-person clinical safety task performed by trained staff.

Draw blood from arteries, using arterial collection techniques.

3

CI 0–5 · exposure 5 · augmentation 25 · importance 4.4/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Healthcare remains a laggard in physical task automation due to liability, regulatory approval timelines, and the embedded human-contact requirement in clinical settings. No evidence of deployment in production phlebotomy workflows.
Sector adoption velocityclaude-sonnet-51/5Healthcare phlebotomy and direct patient-contact procedures show minimal AI displacement; this is a hands-on clinical task in a sector with slow automation adoption for physical procedures.
Augmentation potentialclaude-haiku-4-5-202510012/5AI could assist by identifying optimal veins/arteries via ultrasound imaging analysis or predicting patient-specific anatomical challenges, but the core manual insertion and draw task itself offers minimal room for human-in-the-loop AI assistance today.
Augmentation potentialclaude-sonnet-52/5AI could assist with training, vein/artery localization imaging, or documentation, but offers minimal direct assistance during the actual physical puncture and blood draw process.
Task automatabilityclaude-haiku-4-5-202510011/5Blood draw from arteries requires precise physical manipulation, needle insertion into a moving target, real-time feedback from patient anatomy and vascular response, and immediate error correction. Current AI systems lack embodied robotics with the necessary dexterity, sterility assurance, and adaptive control to perform this task end-to-end reliably.
Task automatabilityclaude-sonnet-51/5Arterial blood collection requires precise physical manipulation of a needle in a small vessel with immediate tactile feedback and safety-critical judgment; no AI system can perform this physical task today.
Adoption barriersclaude-haiku-4-5-202510015/5Arterial puncture is a regulated clinical procedure requiring a licensed healthcare provider (phlebotomist, nurse, or physician) to perform and take responsibility for complications. Strict liability, infection control, and medical licensing requirements create hard legal and regulatory barriers to autonomous automation.
Adoption barriersclaude-sonnet-55/5Arterial blood draws are an invasive medical procedure typically requiring licensed, trained personnel with strict protocols due to high risk of hematoma, nerve damage, or arterial injury, creating hard regulatory and liability barriers.
Cost vs. human wageclaude-haiku-4-5-202510011/5Robotic systems capable of any aspect of phlebotomy cost hundreds of thousands to millions of dollars, with high maintenance and training overhead, far exceeding the cost of a phlebotomist's labor per draw.
Cost vs. human wageclaude-sonnet-51/5There is no viable AI substitute performing this physical procedure, so any AI-based approach would be far more costly (equipment, development, oversight) than a trained phlebotomist performing the draw.
Technical feasibility todayclaude-haiku-4-5-202510012/5No production-deployed AI system performs arterial blood draw autonomously. Limited research prototypes exist in surgical robotics, but they require extensive human supervision, fail on anatomical variation, and have not been validated for safety and regulatory compliance in clinical settings.
Technical feasibility todayclaude-sonnet-51/5No deployed products perform arterial puncture; robotic venipuncture devices remain experimental and none address the more difficult and higher-risk arterial draw in production settings.

Calibrate or maintain machines, such as those used for plasma collection.

3

CI 0–5 · exposure 0 · augmentation 25 · importance 4.2/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Phlebotomy is a hands-on clinical function with minimal AI adoption; plasma collection machines are specialized medical devices where maintenance is performed by certified human technicians following strict protocols.
Sector adoption velocityclaude-sonnet-51/5Healthcare equipment maintenance is a physical, highly regulated domain with minimal AI/robotic adoption for hands-on calibration tasks; this is a laggard segment even within a moderately digitizing healthcare sector.
Augmentation potentialclaude-haiku-4-5-202510012/5AI could provide diagnostic alerts or maintenance scheduling recommendations, but augmentation is limited because the core task—physical calibration and repair—requires human expertise and hands-on interaction with the equipment.
Augmentation potentialclaude-sonnet-52/5AI could offer software-based diagnostic support or predictive maintenance alerts for the machines, but it provides little direct assistance with the physical calibration and upkeep process itself.
Task automatabilityclaude-haiku-4-5-202510011/5Calibration and maintenance of plasma collection machines require hands-on mechanical adjustment, sensor verification, and troubleshooting of complex equipment—tasks that demand physical dexterity and real-time decision-making that current AI systems cannot perform autonomously.
Task automatabilityclaude-sonnet-51/5This requires physical, hands-on manipulation of medical equipment (calibration adjustments, sensor checks, physical maintenance) that current AI systems cannot perform without robotic embodiment, which is not deployed for this purpose today.
Adoption barriersclaude-haiku-4-5-202510015/5Medical device maintenance is heavily regulated (FDA, clinical laboratory standards); equipment calibration typically requires certification and sign-off by qualified technicians, creating strong regulatory and liability barriers to full automation.
Adoption barriersclaude-sonnet-54/5Medical device maintenance is often subject to regulatory and manufacturer certification requirements, and improper calibration carries patient safety risk, creating strong institutional and liability barriers to non-human performance.
Cost vs. human wageclaude-haiku-4-5-202510011/5Specialized technicians and trained phlebotomists perform this maintenance today; the cost of developing, deploying, and overseeing an automated system would far exceed the loaded wage of trained human maintenance staff.
Cost vs. human wageclaude-sonnet-51/5There is no viable AI substitute performing this physical task, so any AI-based approach (e.g., robotics) would be far more expensive than the human phlebotomist performing routine calibration checks.
Technical feasibility todayclaude-haiku-4-5-202510011/5No deployed AI product can reliably calibrate or maintain specialized medical plasma collection equipment; this remains a human-performed task supported at best by diagnostic software, not autonomous AI systems.
Technical feasibility todayclaude-sonnet-51/5No deployed AI product performs physical calibration or maintenance of plasma collection machines; this remains a manual technician task requiring physical dexterity and equipment-specific training.

Dispose of contaminated sharps, in accordance with applicable laws, standards, and policies.

0

CI 0–0 · exposure 0 · augmentation 0 · importance 5.0/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Healthcare waste disposal automation remains in early research phases; regulatory requirements, infection-control standards, and liability concerns have prevented meaningful commercial adoption even in highly digitized healthcare systems.
Sector adoption velocityclaude-sonnet-51/5Healthcare physical waste handling is a low-digitization, manual task with essentially no AI or robotic adoption in this specific function.
Augmentation potentialclaude-haiku-4-5-202510011/5AI offers minimal augmentation to sharps disposal—compliance checklists and digital logging might assist documentation, but the core task of physical safe handling and verification is performed by the human phlebotomist with no meaningful AI productivity gain.
Augmentation potentialclaude-sonnet-51/5AI offers no meaningful assistance for the physical act of disposing of sharps; this remains a fully manual procedural task.
Task automatabilityclaude-haiku-4-5-202510011/5Disposing of contaminated sharps requires physical manipulation of biohazardous materials, adherence to strict protocol verification, and real-time decision-making about waste classification—capabilities that current AI cannot perform end-to-end in a clinical setting.
Task automatabilityclaude-sonnet-51/5This is a physical task requiring manual handling and disposal of biohazardous sharps into containers; no current AI system can perform this physical action.
Adoption barriersclaude-haiku-4-5-202510015/5This task is heavily regulated by OSHA, CDC, and state/local laws requiring specific training certification, documented chain-of-custody, and licensed personnel accountability; automation would face legal and liability barriers that effectively mandate human involvement.
Adoption barriersclaude-sonnet-55/5Strict OSHA/biohazard regulations, licensing, and safety protocols require trained personnel to handle and dispose of contaminated sharps, creating hard legal and safety barriers.
Cost vs. human wageclaude-haiku-4-5-202510011/5Automating this task would require specialized biohazard-handling robots far more expensive than employing a phlebotomist to perform the disposal according to protocol.
Cost vs. human wageclaude-sonnet-51/5There is no AI substitute for this physical action, so AI cost is not comparable to human cost—it cannot be performed by AI at all without robotics.
Technical feasibility todayclaude-haiku-4-5-202510011/5No deployed AI system can autonomously handle, classify, and dispose of sharps waste; this task inherently requires robotics beyond current commercial deployment in healthcare settings and remains outside the scope of software AI.
Technical feasibility todayclaude-sonnet-51/5No deployed product performs physical sharps disposal; this remains entirely a manual, in-person clinical task.

Dispose of blood or other biohazard fluids or tissue, in accordance with applicable laws, standards, or policies.

0

CI 0–0 · exposure 0 · augmentation 0 · importance 4.7/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Healthcare settings remain deeply traditional in biohazard handling due to regulatory requirements and safety-critical nature; adoption of autonomous disposal systems is negligible and unlikely to accelerate significantly.
Sector adoption velocityclaude-sonnet-51/5Healthcare physical waste-handling tasks show minimal AI adoption; this remains a manual, highly regulated process with no automation trend.
Augmentation potentialclaude-haiku-4-5-202510011/5AI provides no meaningful assistance in the actual physical disposal of biohazardous waste; compliance checklists and documentation can be partially automated, but the core task remains fundamentally manual and human-supervised.
Augmentation potentialclaude-sonnet-51/5AI offers no meaningful assistance for the physical act of disposing of biohazard materials, though it might help with documentation or compliance tracking elsewhere.
Task automatabilityclaude-haiku-4-5-202510011/5This task involves physical handling, transport, and disposal of biohazardous materials in compliance with regulations—actions requiring embodied manipulation and real-world safety oversight that current AI systems cannot perform without human intervention.
Task automatabilityclaude-sonnet-51/5This is a physical waste-handling task requiring manual manipulation of hazardous biological materials; no AI system can physically dispose of blood or biohazard waste today.
Adoption barriersclaude-haiku-4-5-202510015/5Strict federal (OSHA, CDC), state, and local regulations require licensed or trained personnel to handle and dispose of biohazardous materials; liability and legal responsibility create hard barriers to autonomous substitution.
Adoption barriersclaude-sonnet-55/5Biohazard disposal is governed by strict regulatory, safety, and licensing requirements (OSHA, state health codes) mandating trained personnel to handle and dispose of such materials, creating hard legal barriers to substitution.
Cost vs. human wageclaude-haiku-4-5-202510011/5Automation would require specialized robotic systems and custom infrastructure that would be far more expensive than paying a trained phlebotomist to perform this routine disposal task.
Cost vs. human wageclaude-sonnet-51/5There is no AI substitute performing this physical task, so AI cost cannot be lower than human cost; a human (or robotic system, not AI per se) must still physically execute disposal.
Technical feasibility todayclaude-haiku-4-5-202510011/5No deployed AI system can autonomously handle, transport, or dispose of blood and biohazardous waste; this requires physical embodiment and is not performed by any production AI system today.
Technical feasibility todayclaude-sonnet-51/5No deployed AI product performs physical biohazard disposal; this remains entirely a manual, in-person process.

Process blood or other fluid samples for further analysis by other medical professionals.

0

CI 0–0 · exposure 0 · augmentation 25 · importance 4.7/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Despite decades of laboratory automation development, adoption of physical sample-processing automation remains confined to high-throughput reference laboratories and large hospital systems, not widespread practice. The majority of clinical settings still rely on human phlebotomists for this task.
Sector adoption velocityclaude-sonnet-51/5Healthcare specimen collection is a low-digitization, physical-contact sector with minimal AI displacement; robotic phlebotomy devices remain experimental and not widely deployed.
Augmentation potentialclaude-haiku-4-5-202510012/5AI could provide minor assistance through automated sample tracking, barcode verification, or data validation to flag potential errors, but these are peripheral to the core manual processing work. AI does not meaningfully augment a phlebotomist's capability to physically process samples.
Augmentation potentialclaude-sonnet-52/5AI can assist with lab information systems, sample tracking, or automated analyzers downstream, but offers little direct augmentation to the physical collection/processing task itself performed by the phlebotomist.
Task automatabilityclaude-haiku-4-5-202510011/5Processing blood samples requires physical manipulation (centrifugation, separation, labeling, handling of biohazardous materials) and sterile technique that current AI systems cannot perform. While data entry and record-keeping associated with samples could be partially automated, the core task of physically processing fluid samples remains entirely manual.
Task automatabilityclaude-sonnet-51/5This is a physical task requiring venipuncture, sample handling, and labeling that current AI systems cannot perform end-to-end; it requires manipulation of physical objects and human bodies.dd
Adoption barriersclaude-haiku-4-5-202510015/5This task has substantial regulatory and legal barriers: clinical laboratory professionals must meet licensure/certification requirements, and blood sample handling is subject to strict CLIA, OSHA, and CAP regulations that mandate human responsibility and oversight for specimen integrity and chain-of-custody procedures.
Adoption barriersclaude-sonnet-55/5Phlebotomy requires certification/licensure in many jurisdictions, involves direct patient contact and bodily fluids, and carries significant liability and infection-control regulations that mandate human performance.
Cost vs. human wageclaude-haiku-4-5-202510011/5Current robotic and AI solutions that could theoretically assist with sample processing are extremely expensive (hundreds of thousands of dollars) and require significant infrastructure, making them far more costly per sample than a phlebotomist's labor for most clinical settings.
Cost vs. human wageclaude-sonnet-51/5There is no viable AI substitute for physical sample collection/processing, so cost comparison favors the human by default since AI cannot perform the task at all.
Technical feasibility todayclaude-haiku-4-5-202510011/5No deployed AI or robotic systems reliably perform the full end-to-end workflow of blood sample processing at scale in clinical settings today. While some laboratory automation exists for specific high-volume steps, these are specialized equipment, not AI systems, and don't constitute general feasibility of AI performing this task.
Technical feasibility todayclaude-sonnet-51/5No deployed AI product performs blood draws or physical fluid sample processing; this remains entirely a manual clinical task performed by trained humans.

Administer subcutaneous or intramuscular injects, in accordance with licensing restrictions.

0

CI 0–0 · exposure 0 · augmentation 13 · importance 4.5/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Healthcare remains one of the slowest sectors to adopt AI for core clinical procedures, particularly invasive ones. No material production adoption of robotic injection systems exists in typical clinical or phlebotomy settings.
Sector adoption velocityclaude-sonnet-51/5Healthcare direct patient-care tasks involving physical procedures show very slow AI adoption due to regulatory, safety, and physical constraints, unlike administrative or diagnostic support functions in the same sector.
Augmentation potentialclaude-haiku-4-5-202510011/5AI offers minimal assistance for the core motor skill of injection itself. AI might help with patient identification or documentation, but does not materially augment the critical task of safe needle insertion and medication delivery.
Augmentation potentialclaude-sonnet-52/5AI may assist with scheduling, documentation, or training simulations related to injections, but offers minimal direct assistance to the physical act of administering the injection itself.
Task automatabilityclaude-haiku-4-5-202510011/5This task requires physical manipulation of needles and precise injection into human tissue, which current AI systems cannot perform. Robotics for medical injection exist only in research settings and lack the dexterity, real-time adaptation, and safety assurance needed for routine clinical use.
Task automatabilityclaude-sonnet-51/5Physical administration of injections requires direct manual contact and dexterity that current AI systems (software or generally available robotics) cannot perform; this is a hands-on clinical task, not an information task.
Adoption barriersclaude-haiku-4-5-202510015/5This task carries hard regulatory and legal barriers: phlebotomists must be licensed, and administering injections must be performed by a licensed healthcare professional under state/federal regulations. Liability for injection errors is high, and legal frameworks explicitly require human licensure for this task.
Adoption barriersclaude-sonnet-55/5Administering injections is a licensed clinical procedure with strict legal, safety, and liability requirements mandating a trained, credentialed human, creating a hard regulatory and safety barrier to automation.
Cost vs. human wageclaude-haiku-4-5-202510011/5Specialized medical robotics capable of safe injection would cost far more than the loaded wage of a phlebotomist, and integration, maintenance, and oversight costs would be prohibitive relative to the simplicity of human performance.
Cost vs. human wageclaude-sonnet-51/5There is no viable AI substitute performing this physical task, so cost comparison favors the human phlebotomist entirely; any robotic alternative would require expensive specialized hardware exceeding human labor costs.
Technical feasibility todayclaude-haiku-4-5-202510011/5No deployed products reliably perform subcutaneous or intramuscular injections in production healthcare settings today. Medical robotics for injection remain experimental and are not integrated into standard phlebotomy or clinical workflows.
Technical feasibility todayclaude-sonnet-51/5No deployed AI product administers injections autonomously in clinical practice today; this remains research-stage robotics at best, not a commercial reality.

Collect fluid or tissue samples, using appropriate collection procedures.

0

CI 0–0 · exposure 0 · augmentation 25 · importance 4.2/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Healthcare adoption of AI for direct patient contact procedures remains minimal; phlebotomy labs have not meaningfully shifted to automated collection systems in production. The sector remains highly conservative on replacing direct-contact clinical tasks.
Sector adoption velocityclaude-sonnet-51/5Healthcare specimen collection is a physical, high-touch task in a sector with slow automation adoption for hands-on clinical procedures; robotic phlebotomy pilots remain rare and not widely deployed.
Augmentation potentialclaude-haiku-4-5-202510012/5AI offers minimal assistance on the core collection task itself (identifying veins, performing puncture, ensuring sample integrity). Limited applications exist for post-collection labeling or documentation, but these are peripheral to the primary phlebotomy function.
Augmentation potentialclaude-sonnet-52/5AI can assist with vein visualization (e.g., infrared vein finders) or workflow/scheduling support, but it provides minimal augmentation to the core physical act of sample collection itself.
Task automatabilityclaude-haiku-4-5-202510011/5Collecting fluid or tissue samples requires direct physical contact with patients, sterile technique, and real-time judgment about sample quality and patient condition. Current AI cannot physically perform venipuncture, handle biohazard materials, or adapt to individual patient anatomy in real-world settings.
Task automatabilityclaude-sonnet-51/5This is a physical, hands-on task requiring manipulation of needles, veins, and patient bodies; no current AI system (software or robotic) can autonomously perform venipuncture or tissue sampling.
Adoption barriersclaude-haiku-4-5-202510015/5Phlebotomy is a licensed or regulated procedure in most jurisdictions; patient consent, direct human contact, and clinical liability create hard barriers. Healthcare regulations typically require a trained, credentialed professional to collect samples to ensure safety, sterility, and legal compliance.
Adoption barriersclaude-sonnet-55/5Direct patient contact, invasive procedures, and safety/liability concerns mean this task legally and practically requires a trained, often certified human, with strict regulatory and clinical oversight.
Cost vs. human wageclaude-haiku-4-5-202510011/5The capital equipment, maintenance, and oversight required for any automated sampling system would substantially exceed the loaded cost of a trained phlebotomist, and current systems cannot match human dexterity and adaptability at any price point.
Cost vs. human wageclaude-sonnet-51/5There is no viable AI/robotic substitute in production, so any comparison favors the human phlebotomist who can be trained and deployed at relatively low cost versus unproven robotic hardware.
Technical feasibility todayclaude-haiku-4-5-202510011/5No deployed AI product performs actual phlebotomy or tissue collection. While robotics exist in research contexts, they are not reliably performing this task in clinical laboratories at scale, and the regulatory and safety barriers are prohibitive.
Technical feasibility todayclaude-sonnet-51/5No deployed product performs autonomous blood draws or tissue collection in clinical settings; robotic venipuncture devices remain experimental/research-stage with very limited real-world deployment.

Related occupations — Healthcare Support

How to read this

A high substitution score does not mean this job disappears — it means a large share of its current tasks face replacement pressure, so the mix of tasks is likely to change. High augmentation alongside substitution typically means the occupation reorganizes around the protected tasks. Wide confidence intervals mean the rater panel disagreed: treat those scores as open questions, not verdicts.

What would change this score

New model capabilities (automatability, feasibility), falling inference costs (cost ratio), regulation and licensing shifts (barriers), and measured sector adoption (velocity) all re-enter at every index release. Each release is recomputed, versioned and kept queryable — scores are claims with a date on them, not permanent labels.